Pfizer Inc.PFENYSE
Loading
Operating Income PerformanceStable
Percentile Rank57
3Y CAGR-25.6%
5Y CAGR+11.2%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
-25.6%/yr
vs +25.2%/yr prior
5Y CAGR
+11.2%/yr
Recent deceleration
Acceleration
-50.8pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $15.44B | -6.3% |
| 2024 | $16.48B | +211.5% |
| 2023 | $5.29B | -85.9% |
| 2022 | $37.55B | +80.6% |
| 2021 | $20.79B | +128.9% |
| 2020 | $9.09B | +21.0% |
| 2019 | $7.51B | -50.9% |
| 2018 | $15.29B | +6.2% |
| 2017 | $14.39B | +0.8% |
| 2016 | $14.27B | - |